Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06125743

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Led by Abramson Cancer Center at Penn Medicine · Updated on 2025-08-14

204

Participants Needed

2

Research Sites

126 weeks

Total Duration

On this page

Sponsors

A

Abramson Cancer Center at Penn Medicine

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

CONDITIONS

Official Title

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 18 years of age
  • Completed primary treatment for head and neck cancer
  • No evidence of cancer currently
  • Completed initial therapy for head and neck lymphedema
  • Unable to obtain further lymphedema therapy due to barriers
  • History of lymphedema on the face and neck, with or without fibrosis
  • Able to understand English to complete questionnaires
  • Able to perform self-care activities for LEF management
  • Able to provide informed consent
  • Have an electronic device (computer, tablet, iPad, or smartphone) and internet access at home
  • Have a valid email address
Not Eligible

You will not qualify if you...

  • Recurrent or metastatic cancer
  • Any other active cancer
  • Acute infection
  • Acute congestive heart failure
  • Acute renal failure
  • Cardiac or pulmonary edema
  • Sensitive carotid sinus
  • Severe carotid blockage
  • Uncontrolled hypertension
  • Venous thrombosis
  • Pregnant people
  • Incarcerated patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

2

Barbara Murphy

Nashville, Tennessee, United States, 37232

Actively Recruiting

Loading map...

Research Team

J

Jie Deng, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here